Scientific Director
Takeda Pharmaceutical Co Ltd
I am Cheryl Li (Ph.D.), Scientific Director of Quantitative Clinical Pharmacology (Oncology) of Takeda Inc.
I am a well-rounded (scientific, strategic, and operational), collaborative, and impact-driven clinical pharmacology leader with a productive 5+ year work history as a Drug Metabolism & Pharmacokinetic (DMPK) lead and Modeling/Simulation expert and 15+ year Clinical Pharmacology Lead experience in Immune-Oncology/Oncology and Inflammation/Immunology at Pfizer and Takeda. My clinical pharmacology skills include early-to-LCM drug development of biologics and small molecules with successful global BLA filings/approvals, model-informed-drug development (MIDD), immunogenicity, translational medicine, pharmaceutical research, and strategy.
Education:
• Ph.D. in Pharmaceutical Sciences (2002), University of Washington, Seattle, WA
• Bachelor of Medicine (1993), Hunan Medical University, Changsha, Hunan, China
Disclosure information not submitted.
Symposium 6: Increasing Diversity in Clinical Trials: What Will It Take for Us to Close the Gap?
Monday, September 9, 2024
8:00 AM – 9:30 AM ET
1 - Clinical Trial Diversity: What Comes to Your Mind?
Monday, September 9, 2024
8:00 AM – 9:30 AM ET